Aiolos Bio
San Francisco, CA
Long Description: Aiolos Bio is a biotech company focused on developing therapies for respiratory diseases like asthma as well as other immune conditions. The company is initially focused on advancing AIO-001, a monoclonal antibody therapy for moderate-to-severe asthma that only requires dosing every 6 months. Aiolos Bio was founded by an accomplished team with decades of drug development experience and leadership in the biotech industry.
aiolosbio.comCompany Details
Founded
- 2023
Employees
- Between 20 - 50 employees
Raised
- $245,000,000
Headquarters Location
- San Francisco, CA
Public
- No
Acquired
- Yes
CEO
Khurem Farooq
Founders
- Khurem FarooqJane Hughes
Company Collections
These are collections Aiolos Bio is a part of. Click on the collection name to view similar companies.
Aiolos Bio's Industries
Aiolos Bio Headquarters Location
San Francisco, CA 94115
Total Amount Raised: $245,000,000
Aiolos Bio Funding Rounds
Series A
$245,000,000
Series A Investors
Atlas VentureBain Capital Life SciencesForbion Capital PartnersSofinnova InvestmentsRA Capital Management
Funding info provided by Diffbot.
Aiolos Bio Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Aiolos Bio.